Myalgic Encephalomyelitis: Clinical Trials

1 trial for Myalgic Encephalomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Myalgic Encephalomyelitis: new trials by email Literature Review of Myalgic Encephalomyelitis trials Research Report on Myalgic Encephalomyelitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
Ampligen - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 3CompletedAIM ImmunoTech Inc.2341998-12-012013-04-17

Narrower conditions

Fatigue Syndrome, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Encephalomyelitis (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

poly(I).poly(c12,U) (1)

Sponsors

AIM ImmunoTech Inc. (1)

Top investigators

David R Strayer, MD (1)

Results publications

PMID 22431963, PMID 33119613